Sevens Research Report Founder and President Tom Essaye interviewed with BNN Bloomberg, says the clarity in the Biden administration and on vaccine development that took place in November is giving investors…Click here to watch the full interview.
“Negative COVID headlines/increased economic lockdowns (especially in NYC and LA County) are starting to offset vaccine optimism, and…” wrote Tom Essaye, founder of The Sevens Report. Click here to read the full article.
“Negative COVID headlines/increased economic lockdowns (especially in NYC and LA County) are starting to offset vaccine optimism…” wrote Tom Essaye, founder of The Sevens Report. Click here to read the full article.
“Negative Covid headlines/increased economic lockdowns (especially in NYC and LA County) are starting to offset vaccine optimism, and that’s…” Tom Essaye, founder of The Sevens Report, said. Click here to read the full article.
“Negative COVID headlines/increased economic lockdowns (especially in NYC and LA County) are starting to offset vaccine optimism…” wrote Tom Essaye, founder of The Sevens Report. Click here to read the full article.
“Negative COVID headlines/increased economic lockdowns (especially in NYC and LA County) are starting to offset…” wrote Tom Essaye, founder of The Sevens Report. Click here to read the full article.
“Because the market is so catalyst driven, there’s going to be volatility in this…” said Tom Essaye, a former Merrill Lynch trader who founded “The Sevens Report” newsletter. Click here to read the full article.
The residual rancor from the presidential election nevertheless has bled into hopes for a fourth stimulus package, according to Tom Essaye of the Sevens Report. He added that “the looming Georgia [Senate] runoffs complicate…” Click here to read the full article.
Stocks extended gains Friday afternoon as the three major averages ended the week on a high note. Tom Essaye, Sevens Report Research Founder joined Yahoo Finance’s Jared Blikre, Seana Smith, and Adam Shapiro to break down market actions on Yahoo Finance Live. Click here to watch the full interview.
“While there will be some discussion about how many people will take the vaccine, and some consternation that it’s a two-dose vaccine that takes 28…” Tom Essaye, founder of the Sevens Report, wrote in a Nov. 9 note. Click here to read the full article.
